VRNA Overview
Upcoming Projects (VRNA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (VRNA)
-
Discussing the commercial potential of Verona's ensifentrine in COPD
Ticker: VRNA
Executed On: Oct 02, 2024 at 11:00 AM EDT -
Discussing the potential of Verona's ensifentrine on indications including asthma, non cystic fibrosis bronchiectasis and cystic fibrosis
Ticker: VRNA
Executed On: Sep 18, 2024 at 04:45 PM EDT -
A second look at Verona Pharma's ensifentrine for the treatment of chronic obstructive pulmonary disease before the PDUFA on June 26th
Ticker: VRNA
Executed On: May 23, 2024 at 01:00 PM EDT -
A look at Verona Pharma's ensifentrine for the treatment of chronic obstructive pulmonary disease before the PDUFA on June 26th
Ticker: VRNA
Executed On: May 23, 2024 at 08:15 AM EDT -
Discussing AATD and COPD, focusing on Inhibrx's INBRX-101 and Verona's ensifentrine
Tickers: INBX, VRNA
Executed On: Sep 27, 2023 at 11:00 AM EDT -
A fourth look at Verona's ensifentrine and its potential in COPD following the results of ENHANCE-2 trial
Ticker: VRNA
Executed On: Oct 04, 2022 at 01:00 PM EDT -
A third look at Verona's ensifentrine and its potential in COPD following the results of ENHANCE-2 trial
Ticker: VRNA
Executed On: Oct 03, 2022 at 02:00 PM EDT -
A Second Look at Verona's ensifentrine and its potential in COPD following the results of ENHANCE-2 trial
Ticker: VRNA
Executed On: Aug 26, 2022 at 01:00 PM EDT -
A look at Verona's ensifentrine in the ENHANCE trial and its potential in COPD
Ticker: VRNA
Executed On: Aug 03, 2022 at 12:00 PM EDT
Upcoming & Overdue Catalysts (VRNA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (VRNA)
-
Verona Pharma (VRNA) Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
Ticker: VRNA
Occurred on: Mar 26, 2018
Strategic Initiatives (VRNA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
